SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Celon Pharma Project to Develop and Evaluate Dual JAK/ROCK Inhibitor

The project aims to develop and clinically evaluate a dual JAK/ROCK inhibitor for myasthenia gravis therapy.

SA

Related stories